Harrow Health, Inc. (HROW)

NASDAQ: HROW · IEX Real-Time Price · USD
8.56
+0.12 (1.42%)
Aug 19, 2022 4:00 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018201720162015201420132012
Revenue
72.4848.8751.1741.3726.7719.949.721.660.010.1
Revenue Growth (YoY)
48.30%-4.48%23.67%54.52%34.26%105.25%485.30%16500.00%-90.00%-
Cost of Revenue
18.2114.4616.7516.5213.519.835.211.0900
Gross Profit
54.2634.4134.4224.8513.2710.114.510.570.010.1
Selling, General & Admin
41.3231.2533.0929.2425.0224.951910.486.082.98
Research & Development
11.082.412.080.830.410.740.330.241.621.3
Other Operating Expenses
0.250.364.04000.30000
Operating Expenses
52.6534.0239.2130.0725.4325.9919.3310.717.74.28
Operating Income
1.610.39-4.8-5.22-12.16-15.88-14.82-10.15-7.69-4.18
Interest Expense / Income
5.442.242.52.733.032.771.11-0.0300.02
Other Expense / Income
14.051.5-7.47-22.57-2.270.54-0.030-0.041.18
Pretax Income
-17.87-3.350.1814.63-12.92-19.2-15.9-10.12-7.64-5.38
Income Tax
0.1300.010-0.94-0.110000
Net Income
-18.01-3.360.1714.63-11.99-19.09-15.9-10.12-7.64-5.38
Preferred Dividends
0.47000000000.2
Net Income Common
-18.48-3.360.1714.63-11.99-19.09-15.9-10.12-7.64-5.58
Net Income Growth
---98.85%-------
Shares Outstanding (Basic)
27262522201310994
Shares Outstanding (Diluted)
27262624201310994
Shares Change
3.33%-2.16%11.15%18.89%57.16%33.07%4.85%5.50%92.65%1029.59%
EPS (Basic)
-0.69-0.130.010.67-0.60-1.50-1.66-1.11-0.88-1.24
EPS (Diluted)
-0.69-0.130.010.61-0.60-1.50-1.66-1.11-0.88-1.24
EPS Growth
---98.36%-------
Free Cash Flow Per Share
0.12-0.08-0.02-0.05-0.48-1.42-1.27-0.79-0.52-0.43
Gross Margin
74.90%70.40%67.30%60.10%49.60%50.70%46.40%34.20%100.00%100.00%
Operating Margin
2.20%0.80%-9.40%-12.60%-45.40%-79.60%-152.60%-611.30%-76868.80%-4178.90%
Profit Margin
-25.50%-6.90%0.30%35.30%-44.80%-95.70%-163.60%-609.50%-76431.20%-5583.50%
Free Cash Flow Margin
4.50%-4.00%-1.00%-2.60%-35.80%-90.80%-124.90%-435.60%-44589.50%-1916.30%
Effective Tax Rate
-0.74%-0.12%4.55%0.00%7.24%0.58%0.00%0.00%0.00%0.00%
EBITDA
-10.041.635.3419.2-8.13-15.02-14.18-10.06-7.64-5.36
EBITDA Margin
-13.90%3.30%10.40%46.40%-30.40%-75.30%-146.00%-606.10%-76374.70%-5355.90%
Depreciation & Amortization
2.42.742.661.841.771.410.610.090.010
EBIT
-12.44-1.122.6817.35-9.89-16.42-14.79-10.15-7.64-5.36
EBIT Margin
-17.20%-2.30%5.20%41.90%-37.00%-82.40%-152.20%-611.30%-76431.20%-5358.90%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).